Microneedles are used for micro-projections of drugs. Microneedles
are the pathways to biological membranes which can create transport
pathways of micron dimensions for sampling body fluids, such as for
measuring the blood glucose levels in diabetic therapy. Microneedle
drug delivery system play an important role in pharmaceutical,
biotechnology and medical industries. Array and microfabrication
technologies are used extensively in medicine, biotechnology and
pharmaceutica research. Microneedle drug delivery system promise
pain-free delivery of both small and large molecular weight active
pharmaceutical ingredients into the viable epidermis avoiding contact
with nerve fibers and blood vessels present in the dermal layers.
However, new developments in biotechnology, microfabrication
technology, allow to demonstrate in vitro, ex vivo, and in vivo
experiments, which is also paving the way for enhancement in the
delivery of drugs.
Report Overview @
https://www.transparencymarketresearch.com/microneedle-drug-delivery-system-market.html
High adoption in number of safety issues that are emerging, which
have short and long term implications for clinicians, patients,
healthcare administrators, and regulators, growing research and
development initiatives, growing demand for safer alternative to
conventional hypodermic injections is the most important driving
factor for microneedle drug delivery system market. According to the
Centers for Disease Control and Prevention, new microneedle patch
could make it easier to vaccinate people against measles and other
vaccine-preventable diseases. Measles being a highly contagious virus
can affect population in large number for which precautions during
vaccine preparation and vaccination should be taken care. Around 20
million people are affected with measles every year and
unfortunately, global coverage with the measles vaccine has been
stagnant for the last few years at around 85% which is below the
coverage percentage. Hence, microneedle patch are designed to
administer by minimally trained workers and also to simplify storage,
distribution, and disposal process. According to WHO, 2015, the
number of cancer new cases is expected to rise by about 70% over the
next 2 decades due to which there can be a demand of microneedle
patches for the drug delivery system. Growth in technologies such as
microneedle patches, rise in transdermal drug delivery applications
for pain management, congestive heart failure and hormone
replacement, will again fuel the overall microneedle drug delivery
system market. Drug degradation, poor absorption, local irritation
and variability in absorption is expected to hamper the microneedle
drug delivery system market growth.
The microneedle drug delivery system market has been segmented by
source type, by technology type, by application type, by end-users
and by geography. In terms of technology type microneedle drug
delivery system market is classified into hollow, porous, solid, and
others. In terms of source type microneedle drug delivery system
market is classified into silicon, metals, polymers, polysaccharides
and others. In terms of application microneedle drug delivery system
market is classified into cardiovascular, oncology, dermatology,
neurology and others. Cardiovascular is highly growing application
segment because of increasing prevalence of cardiovascular diseases
and stroke globally. According to WHO, 17.5 million people died from
cardiovascular diseases in 2012, representing 31% of all the global
deaths. Of these deaths, an estimated 7.4 million were due to
coronary heart disease and 6.7 million were due to stroke. In terms
of end users microneedle drug delivery system market is classified
into diagnostic laboratories, life sciences and research
laboratories, hospitals, ambulatory surgical centers, and others.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30503
Geographically microneedle drug delivery system market is classified
into North America, Latin America, Europe, Asia Pacific, and Middle
East & Africa. Geographically North America dominates the global
microneedle drug delivery system market due to patient awareness with
high per capita health care expenditure. Early-phase diagnosis and
treatment of disease, and easy regulations for transdermal drug
delivery vaccines is driving the medical biotechnology market which
in turn is expected to drive the microneedle drug delivery system
market in North America. Europe is the second largest market for
microneedle drug delivery system as there are favorable government
policies regarding health care infrastructure and awareness of
contagious diseases. Asia Pacific is expected to grow at higher rate
due to rising population, changing lifestyle, rising awareness
between patients and increasing per capita expenditure. In addition,
economic growth and improving the efficacy of cosmetic products is
supporting the health care infrastructure improvement in developing
countries such as India and China. Thus, all the above mentioned
factors collectively support the growth of microneedle drug delivery
system market for Asia Pacific region and expected to propel the
market share of the segment by 2025.
The major players operating in the global microneedle drug delivery
system include 3M, Vetter Pharma International GmbH, nanoBioSciences
LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation,
Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies,
Innoture Medical Technology Limited, Phillips Plastic Corporation,
Corium International, Inc., Stemedica Cell Technologies, Inc., and
among others.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=30503<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment